Jiangsu Hengrui Pharmaceutical in China

Clinical Trials sponsored by Jiangsu Hengrui Pharmaceutical

About Jiangsu Hengrui Pharmaceutical

Jiangsu Hengrui Pharmaceutical Co., Ltd. is a pharmaceutical and health company engaged in pharmaceutical innovation and high-quality drug R&D, production and promotion. It was founded in 1970 and listed on the Shanghai Stock Exchange in 2000. As of the end of 2019, it has more than 24,000 employees worldwide. It is a well-known domestic supplier of anti-tumor drugs, surgical drugs and contrast agents, and is also the lead unit of the National Anti-tumor Drug Technology Innovation Industry-University-Research Alliance. It has established a national targeted drug engineering technology research center and a post-doctoral research station. In 2019, the company achieved operating income of 23.29 billion yuan and taxation of 2.43 billion yuan, and was selected into the TOP50 list of global pharmaceutical companies, ranking 47th.